Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
CERE
Company Announcements
Cerevel Therapeutics’ Corporate Transformation and Market Delisting
11M ago
8K
CERE
Premium
The Fly
AbbVie completes acquisition of Cerevel Therapeutics
11M ago
ABBV
CERE
Premium
Pre-Earnings
CERE Upcoming Earnings Report: What to Expect?
11M ago
CERE
Premium
The Fly
AbbVie expects Cerevel Therapeutics transaction to close ‘soon’
11M ago
ABBV
CERE
Premium
The Fly
Cerevel Therapeutics weakness attributed to CTFN report
12M ago
ABBV
CERE
Premium
The Fly
Soros buys Okta, cuts Amazon in Q1
1y ago
AER
CRH
Premium
Pre-Earnings
CERE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1y ago
CERE
Premium
The Fly
Cerevel Therapeutics’ tavapadon meets Phase 3 primary endpoint in Parkinson’s
1y ago
CERE
Premium
Pre-Earnings
CERE Upcoming Earnings Report: What to Expect?
1y ago
CERE
Premium
Company Announcements
Cerevel Therapeutics Advances in Merger Amid FTC Review
1y ago
8K
CERE
Premium
The Fly
Cerevel Therapeutics price target raised to $45 from $25 at Mizuho
1y ago
CERE
Premium
The Fly
Neurocrine price target raised to $106 from $100 at Piper Sandler
1y ago
CERE
KRTX
Premium
The Fly
Neumora Therapeutics appoints Panandiker as Chief Commercial Officer
1y ago
CERE
NMRA
Premium
The Fly
Cerevel Therapeutics price target raised to $45 from $25 at JPMorgan
1y ago
ABBV
CERE
Premium
The Fly
Karuna downgraded, Arm target raised: Wall Street’s top analyst calls
1y ago
ARM
BMY
Premium
The Fly
Reviva may be most undervalued in neurology, says H.C. Wainwright
1y ago
CERE
KRTX
Premium
The Fly
Cerevel Therapeutics price target raised to $45 from $30 at Wells Fargo
1y ago
ABBV
CERE
Premium
The Fly
Cerevel Therapeutics downgraded to Hold from Buy at Jefferies
1y ago
CERE
Premium
The Fly
Cerevel Therapeutics downgraded to Hold from Buy at Stifel
1y ago
CERE
Premium
The Fly
Cerevel Therapeutics just downgraded at Stifel, here’s why
1y ago
CERE
Premium
The Fly
The biopharma stocks to own in 2024, according to Morgan Stanley
2y ago
BMY
JNJ
Premium
The Fly
The biopharma stocks to own in 2024, according to Morgan Stanley
2y ago
BMY
JNJ
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
